Listed Company Update | AJJ Medtech (SGX: 584) Secures Institutional Supply Contract
AJJ Medtech announced a new institutional medical supply contract worth approximately S$3 million, covering biodegradable medical consumables. The contract starts on 1 June 2026, with an initial 2-year term and an extension option, while the company’s cumulative institutional revenue pipeline now exceeds S$8 million.
[AI-readable]
Company: AJJ Medtech Holdings Limited
Ticker: SGX: 584
Announcement Date: 9 March 2026
Announcement Title: AJJ Medtech Secures S$3M Institutional Contract for Biodegradable Medical Consumables
Contracting Entity: AJJ Healthcare Management Pte. Ltd. (wholly owned subsidiary)
Customer Type: A network of Singapore healthcare institutions
Contract Value: Approximately S$3 million
Product Category: Biodegradable medical consumables
Commencement Date: 1 June 2026
Contract Term: Initial two-year term with an option to extend for a further two years
Institutional Revenue Pipeline: Exceeds S$8 million
Financial Impact: Not expected to have a material impact on current financial year NTA or EPS; expected to contribute positively over the contract tenure.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
